About
Miromatrix Medical is a biotechnology company that is a leader in developing bioengineered organs for transplantation. The company has over 118 issued patents worldwide with a technology that can be applied across a range of donor needs. They are focused on developing kidneys (MiroKidney) and livers (MiroLiver) that are transplantable with additional plans for other critical organs like lungs, pancreases and hearts. The company's technology has been tested extensively both in preclinical and animal studies and has been cleared by the FDA in a previously commercialized matrix product.